Facebook tracking pixel
S10.AI
ICD-10-CM · E29.1GeneralSystemic

Testosterone Deficiency

Find information on Testosterone Deficiency diagnosis, including clinical documentation, medical coding (ICD-10, SNOMED CT), symptoms, treatment, and lab tests. Learn about hypogonadism, low testosterone levels, male andropause, and hormone replacement therapy. Explore resources for healthcare professionals on diagnosing and managing testosterone deficiency in men. This resource covers relevant medical terms for accurate documentation and coding related to androgen deficiency.

Also known as
Low TestosteroneHypogonadism
Definition

No summary description available.

Clinical signs

N/A

Common settings

Outpatient / Inpatient Clinical Encounters

Related Codes

ICD-10 Code Families

Complete code families applicable to E29.1

E29.1
Testicular dysfunction
E30.0
Delayed puberty, male
Q98.0-Q98.9
Chromosomal abnormalities
Code Comparison

When to use each related code

DescriptionWhen to use
Low testosterone levels in men.Adult males with sexual dysfunction, fatigue, low libido, confirmed by low serum testosterone.
Late-onset hypogonadism.Older males with gradual onset of testosterone deficiency symptoms, consider age-related decline.
Klinefelter syndrome (47,XXY).Genetic condition in males with extra X chromosome, often causing infertility and low testosterone.
Documentation

Best-practice checklist

  • Signs/symptoms of low T (fatigue, low libido)
  • Total testosterone level <300 ng/dL (two separate measurements)
  • Free/bioavailable testosterone if total T 300-500 ng/dL
  • Exclude other causes of low T (chronic illness, meds)
  • Document response to testosterone therapy if initiated
Coding & Audit Risks

Common pitfalls to avoid

Unspecified Diagnosis

Coding with unspecified testosterone deficiency (e.g., E29.1) without documented clinical support for a more specific code creates audit risk.

Lack of Medical Necessity

Insufficient documentation of symptoms, exam findings, and lab results supporting medical necessity for testosterone testing and treatment poses compliance and coding risks.

Age-Related Deficiency vs. Hypogonadism

Miscoding age-related decline in testosterone (normal aging) as hypogonadism (e.g., E29.1, D29.1) leads to inaccurate coding and potential denial of claims.

Mitigation

Best-practice tips

  • 01Verify ICD-10-CM codes (e.g., D29.1, 78.49) accuracy for TD diagnosis.
  • 02Document signs/symptoms, lab results (total, free T), and SHBG levels.
  • 03Evaluate comorbidities impacting testosterone (e.g., obesity, diabetes).
  • 04Implement standardized clinical pathways for TD diagnosis & treatment.
  • 05Follow payer-specific guidelines for prior authorizations of TRT.
Clinical Decision Support

Step-by-step checklist

  1. 1

    Verify low serum testosterone level (e.g., <300 ng/dL)

  2. 2

    Confirm symptoms consistent with TD (e.g., fatigue, low libido)

  3. 3

    Exclude secondary causes (e.g., pituitary disorders)

  4. 4

    Document symptom onset, duration, and severity

  5. 5

    Review medication list for potential drug interactions

Documentation Template

Ready-to-paste narrative

Patient presents with symptoms suggestive of testosterone deficiency (hypogonadism), including fatigue, decreased libido, erectile dysfunction, and reduced muscle mass.  He reports a gradual onset of these symptoms over the past year.  Review of systems reveals difficulty concentrating, depressed mood, and decreased energy levels.  Past medical history is significant for hypertension, managed with lisinopril.  Family history is noncontributory.  Physical examination reveals normal testicular size and no gynecomastia.  Initial laboratory evaluation includes a morning serum total testosterone level, free testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH).  Differential diagnosis includes primary hypogonadism, secondary hypogonadism, and age-related decline in testosterone.  Based on the patient's clinical presentation and pending laboratory results, the current assessment is consistent with possible male hypogonadism.  A treatment plan will be formulated following review of laboratory data and may include testosterone replacement therapy (TRT), lifestyle modifications such as diet and exercise, and management of comorbid conditions.  Patient education will address the benefits and risks of testosterone therapy, potential side effects, and the importance of follow-up monitoring of testosterone levels, hematocrit, and prostate-specific antigen (PSA).  ICD-10 code E29.1 (Testicular hypofunction) or E23.0 (Hypogonadotropic hypogonadism) may be applicable depending on laboratory results.  CPT codes for laboratory testing and follow-up visits will be documented accordingly. The patient was advised to return for follow-up in four weeks to review laboratory results and discuss treatment options.

Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.

Coding standard: ICD-10-CM, current FY guidelines.